[1]
S. Sherman, E. S. Cohen, I. Amitay-Laish, E. Hodak, and L. Pavlovsky, “IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience”, Acta Derm Venereol, vol. 99, no. 9, pp. 769–773, May 2019.